• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problem Perivalvular Leak (1457)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 01/25/2024
Event Type  Injury  
Event Description
The perceval valve pvs23 was implanted on (b)(6) 2024 with mics (rat).Pvl was mild.On 25 january 2024, pvl was noted and judged to be more than moderate with tte.As such, the re-operation was done with median sternotomy.Ballooning was done for perceval, but it did not work so the valve was explanted and replaced with inspris 21mm.Right after the surgery, the blood platelet was getting low but improved to 50,000.Before the re-operation, blood platelet was 13,000.No transfusion or dialysis has been done so far.
 
Manufacturer Narrative
The device was returned to the manufacturer.After decontamination, the valve was visually inspected without observing any macroscopic anomalies and/or pre-existing defects according to the specifications.The organic material / coagulated blood, found on the prosthesis, can be consistent with the incoming steps of the process of endothelization between the annulus and the pericardial surface along the fourteen (14) days of implanting time.From the visual analysis of the aforementioned residues, it is not possible to establish with certainty a correlation between their distribution and a specific area in which the reported pvl was hypothetically located.The replication of collapsing phases was performed using the returned valve pvs 23/m and a demo accessory kit, in order to attempt to reproduce the reported event.No problems were encountered in the collapsing phase, and the replication has been completed with a good result.During the simulation of the valve deployment in silicon aortic root #23, no problems were encountered during the ballooning phase: the sealing at the annulus level is guaranteed as visible in attached pictures; thus, the valve remained fixed within the annulus.Then, inserting some water in the aortic root from the outflow side, no paravalvular leaks were observed during the simulations.Considering the static conditions of the test and despite the residual of organic material on the external surface of the pericardial skirt, the water level remained stable under the leaflets free edge.Based on the information available, the definitive root cause of the reported event cannot be established at this time.However, based on the performed analyses, the reported event cannot be explained by any factor intrinsic in the involved device.Furthermore, from the document review performed, no manufacturing deficiencies were noted.Should further information be received in the future, a follow up report will be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
laura mannino
5005 north fraser way
burnaby, bc 
MDR Report Key18744489
MDR Text Key335812181
Report Number3004478276-2024-00115
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/20/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/01/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/06/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age81 YR
Patient SexMale
Patient Weight68 KG
-
-